Barentz Opens New Pharma Office in North America to Strengthen Local Presence and Partnership

Hoofddorp, Netherlands, June, 2, 2026 — Barentz, a leading global specialty ingredients solution provider, announces the opening of its new office for its Pharmaceuticals division in Chesterbrook, Pennsylvania. This milestone reflects the company’s continued investment in the region and its commitment to strengthening partnerships, enhancing collaboration, and supporting the growth of its pharmaceutical business. 

The new office will serve as a central hub for Barentz’s Pharma activities in North America. Designed as a commercial office, it brings teams together in one location to improve coordination, enable faster response times, and further strengthen relationships with customers and principal partners. 

Located in the Philadelphia area, the office was strategically selected for its proximity and accessibility to key principals, customers, and partners. This allows Barentz to collaborate more closely with stakeholders, support faster market access, and operate at greater scale across the region. 

“This opening symbolizes the power of partnerships,” said Divya Tewari, President Pharmaceuticals North America. “Our progress in North America has only been possible thanks to the trust of our customers and principal partners, as well as the dedication of our team. This is truly a shared achievement.” 

The new location allows Barentz to be closer to its customers and partners, supporting more effective collaboration and reinforcing long-term relationships across the region. It also supports the company’s broader growth strategy for its Pharma business in North America by strengthening its local presence and enhancing its ability to serve the market. 

“For us, this is a proud milestone that reflects the journey we’ve been on over the past six years in North America,” Divya added. “This new space is designed to bring people together, spark collaboration, and create more opportunities to work side by side with our partners and customers on solutions that contribute to improved patient outcomes.” 

More than just a new office, the space represents Barentz’s commitment to building an environment where expertise, collaboration, and purpose come together to drive meaningful impact in the pharmaceutical landscape.